AGP-3 Activators refer to a niche of compounds that exert a direct or indirect influence on the functional activity of AGP-3. These activators operate through unique signaling pathways or biological processes, distinct from general transcriptional or translational enhancement, ensuring a specific impact on AGP-3's activity. The chemical compounds that serve as AGP-3 Activators are not generic in their action but are instead tailored to influence the exact biochemical routes that AGP-3 is known to participate in or regulate. For instance, some activators may target second messenger systems, such as cAMP or calcium signaling pathways, which have downstream effects on kinases that directly modulate AGP-3's activity. Others may inhibit specific kinases or phosphatases, leading to an altered phosphorylation state of proteins within the AGP-3 signaling cascade, thus indirectly enhancing AGP-3 function.
The modulation of AGP-3 through these activators is achieved through precise and targeted interactions with the relevant signaling components. For example, some activators may enhance AGP-3 activity by binding to and inhibiting proteins that normally restrain AGP-3-associated pathways, thereby releasing such inhibition and allowing AGP-3 to function more effectively. Other compounds might increase the availability or efficacy of secondary messengers or cofactors required for AGP-3 activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Directly stimulates adenylyl cyclase, increasing cAMP levels, which may enhance AGP-3 activity through PKA-mediated signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-selective phosphodiesterase inhibitor, raises intracellular cAMP by preventing its breakdown, potentially enhancing AGP-3 activity via PKA-dependent mechanisms. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which could enhance AGP-3 activity by phosphorylation of proteins within AGP-3 related pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, which could activate calcium-dependent protein kinases that modulate AGP-3 activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor, could indirectly enhance AGP-3 activity by modulating phosphorylation states within its signaling network. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Chelates intracellular calcium, potentially enhancing AGP-3 activity by affecting calcium-dependent signaling pathways. | ||||||